Frédéric Lévy

Investor

Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund

About

Chief Scientific Officer for Search & Evaluation and Scientific Innovation, having joined Debiopharm International in 2008. He holds a doctorate from the Karolinska Institute and previously led work at the Ludwig Institute for Cancer Research.

Colleagues at Debiopharm Innovation Fund

Angela Zubel

Chief Development Officer, Research & Development at Debiopharm Innovation Fund

Bertrand Ducrey

Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund

Cedric Odje

Investment Associate at Debiopharm Innovation Fund

Marc Cikes

Managing Director at Debiopharm Innovation Fund

Nicolas Favre

Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund

Nicolas Stalder

Senior Investment Associate at Debiopharm Innovation Fund

Pierre Jullian

Chief Finance Officer, Finance, HR, IT & Administration at Debiopharm Innovation Fund

Sara Picó

Investor at Debiopharm Innovation Fund

Frequently asked questions

Who is Frédéric Lévy?: Chief Scientific Officer for Search & Evaluation and Scientific Innovation, having joined Debiopharm International in 2008. He holds a doctorate from the Karolinska Institute and previously led work at the Ludwig Institute for Cancer Research.
Where does Frédéric Lévy work?: Frédéric Lévy is Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund.